Cambridge Investment Research Advisors
IBDQ

Cambridge Investment Research Advisors’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-198,501
Closed -$5M – 3886
2025
Q3 		$5M Sell
198,501
-14,014
-7% -$352K 0.01% 917
2025
Q2 		$5.35M Sell
212,515
-22,311
-10% -$560K 0.02% 817
2025
Q1 		$5.91M Buy
234,826
+12,368
+6% +$311K 0.02% 715
2024
Q4 		$5.57M Buy
222,458
+28,796
+15% +$721K 0.02% 746
2024
Q3 		$4.86M Buy
193,662
+20,002
+12% +$499K 0.02% 809
2024
Q2 		$4.32M Buy
173,660
+37,654
+28% +$933K 0.02% 833
2024
Q1 		$3.37M Buy
136,006
+13,139
+11% +$325K 0.01% 966
2023
Q4 		$3.04M Buy
122,867
+12,739
+12% +$312K 0.01% 963
2023
Q3 		$2.68M Sell
110,128
-52,503
-32% -$1.28M 0.01% 969
2023
Q2 		$3.96M Buy
162,631
+12,225
+8% +$299K 0.02% 775
2023
Q1 		$3.69M Buy
150,406
+62,997
+72% +$1.54M 0.02% 779
2022
Q4 		$2.13M Buy
87,409
+4,476
+5% +$108K 0.01% 1049
2022
Q3 		$2M Buy
82,933
+63,678
+331% +$1.57M 0.01% 1027
2022
Q2 		$476K Sell
19,255
-13,914
-42% -$346K ﹤0.01% 2000
2022
Q1 		$838K Buy
33,169
+9,998
+43% +$258K ﹤0.01% 1697
2021
Q4 		$612K Sell
23,171
-5,048
-18% -$134K ﹤0.01% 1947
2021
Q3 		$758K Sell
28,219
-9,622
-25% -$260K ﹤0.01% 1746
2021
Q2 		$1.02M Buy
37,841
+256
+0.7% +$6.91K ﹤0.01% 1518
2021
Q1 		$1.01M Buy
37,585
+3,757
+11% +$102K 0.01% 1430
2020
Q4 		$926K Buy
33,828
+6,492
+24% +$177K 0.01% 1359
2020
Q3 		$742K Buy
27,336
+11,970
+78% +$325K 0.01% 1359
2020
Q2 		$415K Buy
15,366
+737
+5% +$19.3K ﹤0.01% 1666
2020
Q1 		$365K Buy
14,629
+3,268
+29% +$84.2K ﹤0.01% 1558
2019
Q4 		$295K Buy
11,361
+648
+6% +$16.8K ﹤0.01% 1920
2019
Q3 		$277K Buy
10,713
+2,560
+31% +$65.8K ﹤0.01% 1887
2019
Q2 		$209K Buy
+8,153
New +$204K ﹤0.01% 1977

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cambridge Investment Research Advisors's IBDQ Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 198,501 shares — an estimated $5M sold.

Cambridge Investment Research Advisors first reported a position in IBDQ in Q2 2019 and held it in 26 quarters. The position peaked at $5.91M in Q1 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 198,501 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $5M.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2019 and held it in 26 quarters.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $5.91M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.